The Latest Breaking News from Tempus

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point to significant upside potential.

The popular investor poured $366.2 million in the company’s shares to carry out her latest purchase.

Annabel Grossman checks in

AI healthcare stock Tempus AI has seen its value fall off a cliff recently. However, Wall Street remains bullish, seeing significant upside in the shares.

Cathie Wood is shifting away from Tesla, zeroing in on an AI-driven healthcare firm that is revolutionizing precision medicine and advanced diagnostics.

This AI diagnostics stock is a holding in Wood's ARKK and ARKG ETFs.

Big debuts from Reddit and Astera Labs are raising hope the IPO market has finally rebounded. But it’s still not the soaring, go-go days of 2021.

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

The county is in for another big year of tourism if the popular travel and culture magazine's list is anything to go by!